Effects of Diet Selection Based on Genetic Screening on Success to a Weight Loss Program
Curves3
Effects of Diet Type Selection Based on Response to a Carbohydrate Intolerance Questionnaire and Genetic Screening on Success to a Weight Loss and Exercise Program
1 other identifier
interventional
51
0 countries
N/A
Brief Summary
The purpose of this study is to determine the effects of diet type selection based on response to a Carbohydrate Intolerance Questionnaire (CIQ) and genetic screening on success to a weight loss and exercise program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2013
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
March 29, 2017
CompletedFirst Posted
Study publicly available on registry
April 17, 2017
CompletedApril 17, 2017
March 1, 2017
1.7 years
March 29, 2017
April 11, 2017
Conditions
Outcome Measures
Primary Outcomes (11)
Effects of diet selection on physical activity patterns changes (steps per day)
24 weeks
Effects of diet selection on body weight changes (pounds)
24 weeks
Effects of diet selection on hip/waist ratio changes (inches)
24 weeks
Effects of diet selection on Resting Energy Expenditure (REE) changes (calories per day)
24 weeks
Effects of diet selection on Blood Pressure (BP) changes (mmHG)
24 weeks
Effects of diet selection on Heart Rate (HR) changes (beats per minute)
24 weeks
Effects of diet selection on body composition (DXA) changes (percent fat mass)
24 weeks
Effects of diet selection on Bioelectrical Impedance Analysis (BIA) changes (flow impedance)
24 weeks
Effects of diet selection on a chemistry-15 blood panel changes
24 weeks
Effects of diet selection on a cell blood count (CBC) blood panel changes
24 weeks
Effects of diet selection on lipid panel changes
24 weeks
Secondary Outcomes (5)
Effects of diet selection on maximal cardiopulmonary capacity changes (ml/kg/min)
24 weeks
Effects of diet selection on muscular strength through a 1 repetition maximum (1 RM) test
24 weeks
Effects of diet selection on muscular endurance through a maximal repetition test
24 weeks
Effects of diet selection on gene expression changes
24 weeks
Effects of diet selection on DNA methylation changes
24 weeks
Study Arms (4)
Positive CIQ plus High Carbohydrate Diet
ACTIVE COMPARATORPositive Carbohydrate Intolerance Questionnaire (CIQ) plus 30% carbohydrate, 45% protein, 25% fat diet
Positive CIQ plus High Protein Diet
ACTIVE COMPARATORPositive Carbohydrate Intolerance Questionnaire (CIQ) plus 20% carbohydrate, 45% protein, 35% fat diet
Negative CIQ plus High Carbohydrate Diet
ACTIVE COMPARATORNegative Carbohydrate Intolerance Questionnaire (CIQ) plus 30% carbohydrate, 45% protein, 25% fat diet
Negative CIQ plus High Protein Diet
ACTIVE COMPARATORNegative Carbohydrate Intolerance Questionnaire (CIQ) plus 20% carbohydrate, 45% protein, 35% fat diet
Interventions
Positive Carbohydrate Intolerance Questionnaire plus High Carbohydrate Diet
Positive Carbohydrate Intolerance Questionnaire plus High Protein Diet
Negative Carbohydrate Intolerance Questionnaire plus High Carbohydrate Diet
Negative Carbohydrate Intolerance Questionnaire plus High Protein Diet
Eligibility Criteria
You may qualify if:
- The participant is an apparently healthy female
- The participant is between the ages of 18 and 60
You may not qualify if:
- The participant is pregnant or nursing, or plans to become pregnant during the next 12 months or has been pregnant in the past 12 months
- The participant has uncontrolled metabolic disorder including known electrolyte abnormalities; heart disease, arrhythmias, diabetes, thyroid disease, or hypogonadism; a history of hypertension, hepatorenal, musculoskeletal, autoimmune, or neurological disease
- The participant is currently taking thyroid, hyperlipidemic, hypoglycemic, anti-hypertensive, or androgenic medications
- The participant has taken ergogenic levels of nutritional supplements that may affect muscle mass (e.g., creatine, HMB), anabolic/catabolic hormone levels (androstenedione, DHEA, etc.) or weight loss (e.g., ephedra, thermogenics, etc.) within the past three months
- The participant is willing to take participate in a regular moderate exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Texas A&M Universitylead
- Curves Internationalcollaborator
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard B Kreider, PhD
Texas A&M University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2017
First Posted
April 17, 2017
Study Start
November 1, 2013
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
April 17, 2017
Record last verified: 2017-03
Data Sharing
- IPD Sharing
- Will not share